abstract |
The present application is mediated by N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, novel P2X7R antagonists, pharmaceutical compositions comprising such compounds, and P2X7R activity. To their use in prophylactic or therapeutic treatment of diseases. |